My Moderna, BioNtech, Arcturus, Nio , Xpeng , Li etc all rocketing in multi-baggers while my sgx stocks creeping like a tortoise.
Fortunately, I diversify in US market.
No wonder those private equity likes to come here and buy those cash-rich companies with low PE and privatise them, then re-list them again at higher PE in oversea market.
Even that Perennial big shareholders with billionaire status also short-changed their minority shareholders by privatising the company at 0.6x book value.
lol, that Alset rise bcos of the parent company HF Enterprise is 'thinking' of going public in NASDAQ, which has nothing to do with Alset since there is no material impact on their earnings.
Moreover, DSS hasn't budged after they 'bought' the IP from Alset.
worst, the MTM biz iGalan website is gone, the Linebacker they were boasting about before the covid came around has not proven any results while Pfizer and Moderna already seeking approval for emergency use and still no picture from them.
this is just another copycat of another concept stock, lmao.
Singapore’s co-developed vaccine candidate is in ‘good shape’ for delivery in 2021
PUBLISHED THU, NOV 26 202011:31 PM EST
Positive interim results were announced by Singapore’s Covid vaccine candidate ARCT-021, developed by Arcturus Therapeutics in collaboration with scientists from the Duke-NUS Medical School in Singapore.
The ability of the Arcturus vaccine to be delivered in a low dose differentiates it from many other Covid vaccines in development, Joseph Payne, president and CEO of Arcturus Therapeutics, told CNBC.
Shipments are expected to begin in the first quarter of 2021.
If u are looking for post-covid recovery stock in the hospitality sector, u may want to consider this company.
Executive Summary 1H2020
Revenue decreased by 43% to S$75.4 million
Core Operating Profit1 decreased by S$33.9 million due to lower contribution from Hotel Investments and Fee-based segments, partially cushioned by a higher contribution from the Residences and Extended Stay
segment2
Repayment of the final tranche of medium-term notes in June 2020 of S$100 million
Successful completion of convertible bond rights issue of S$50.4 million. The bonds can be converted to shares at the exercise price of $0.25 which means 1 bond to 4 shares
Sustained organic portfolio growth with 8 new hotels and 7 spas opening in the next 12 months, representing an 18% growth in room key count
Cash-preservation measures in place for sufficient operating runway into 2021
NAV $0.75
Technical: A golden-cross just happened
Pipeline and Outlook
The Group’s brands continue to show optimism with notable achievements and a pipeline gaining momentum,completing 13 hotel management agreements this year, with strong traction shown across all brands.
It has receiveda total of 38 awards as of 30 June 2020, totaling to 2649 awards. Notable recent awards include 2020 Forbes TravelGuide Five-Star Ratings for Hotel, Spa and Restaurant for Banyan Tree Macau; DestinAsian 15th Readers'Choice Awards 2020 Best Hotels & Resorts in Vietnam, Maldives, Thailand, Macau and Malaysia for BanyanTree Lăng Cô, Banyan Tree Vabbinfaru, Banyan Tree Phuket, Banyan Tree Macau and Banyan Tree Kuala Lumpur respectively; Harper's Bazaar
Best Rainforest Spa Experience for Banyan Tree Samui; Golf Digest US Editors'Choice Awards Best Golf Resorts In Asia (4th consecutive year) for Laguna Lăng Cô. For its Residences and extended Stay segment, Skypark Phuket is the winner of International Property Awards 2020 for three categories - Apartment/Condominium, Residential Interior Show Home and Development Marketing.
In the next 12 months, the Group expects to open 8 new resorts and 7 new spas across the 7 geographies of Thailand, Malaysia, Indonesia, China, Qatar, Mozambique and Greece, of which the latter 3 represent new markets. Over the next 3 years, 46 new properties are expected to open in line with the Group’s ambition to double its operating footprint by 2025.–
Banyan Tree Holdings Limited (“Banyan Tree” or the “Group”) is one of the world’s leading independent, multi-branded hospitality groups.
The Group’s diversified portfolio of hotels, resorts, spas, galleries, golf and residences is centered on five award-winning brands (Banyan Tree, Angsana, Cassia, Dhawa and Laguna) that offer exceptional design-led experiences for global travellers of today and tomorrow.
